Patent №
US 11,617,746
Granted
2023-04-04
Filed 2021
Owner
OREXO AB
Lab
—
AI components
2
nlp · planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
17363877
The present disclosure is directed to a method of combatting opioid dependence in a subject experiencing a depressive episode. The method comprises treating the subject with an opioid agonist whilst managing their depression or depressive disorder using a step-wise interactive process, particularly where the process involves virtual cognitive behavioral therapy comprising a program for self-treatment. The self-treatment program could be embodied as a mobile medical application.
AI classification
Ownership
OREXO AB
assignment · 574430273
Assignors
SUMNER, MICHAEL JOHN
On an employer assignment, the assignors are typically the inventors.